113. Muscular dystrophy Clinical trials / Disease details

Clinical trials : 646 /  Drugs : 471 - (DrugBank : 105) / Drug target genes : 59 - Drug target pathways : 170

  
10 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03067831
(ClinicalTrials.gov)		September 201525/2/2017Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular DystrophySafety and Efficacy of Purified Autologous Bone Marrow-Derived Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy.Duchenne Muscular DystrophyBiological: Stem CellsStem Cells ArabiaNULLRecruiting4 Years25 YearsAll20Phase 1/Phase 2Jordan
2NCT02484560
(ClinicalTrials.gov)		June 201516/6/2015Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2Efficacy of Allogenic Mesenchymal Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2Duchenne Muscular DystrophyDrug: Biological: Umbilical Cord Based Allogenic Mesenchymal Stem CellUniversity of GaziantepIstinye University, Cukurova University, Yildirim Beyazit University, Gaziantep Deva Hospital, Gaziantep Public HospitalActive, not recruiting8 Years14 YearsMale10Phase 1Turkey
3NCT01834066
(ClinicalTrials.gov)		September 201426/2/2013Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy.Safety and Efficacy of Bone Marrow Autologous Cells in Muscular Dystrophy. It is Self Funded (Patients' Own Funding) Clinical TrialMuscular Dystrophy;Duchenne Muscular Dystrophy,Biological: Stem CellChaitanya Hospital, PuneNULLRecruiting6 Years25 YearsBoth25Phase 1/Phase 2India
4NCT02235844
(ClinicalTrials.gov)		September 20148/9/2014Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)Allogeneic Transplantation of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)Duchenne's Muscular DystrophyBiological: Umbilical Cord Mesenchymal Stem CellsAllergy and Asthma Consultants, Wichita, KansasAidan Foundation;Neil H. Riordan PhDCompleted28 Years31 YearsMale1Phase 1United States
5NCT02285673
(ClinicalTrials.gov)		November 20135/11/2014Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular DystrophyEfficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy: Phase 1/2 StudyDuchenne Muscular DystrophyBiological: Umbilical Cord Mesenchymal Stem CellAcibadem UniversityNULLRecruiting7 Years20 YearsMale10Phase 1/Phase 2Turkey
6NCT01610440
(ClinicalTrials.gov)		October 201121/5/2012Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular DystrophyPhase I/II Study of Stem Cell Therapy in Patients With Duchenne Muscular DystrophyDuchenne Muscular DystrophyBiological: human umbilical cord mesenchymal stem cellsShenzhen Beike Bio-Technology Co., Ltd.The Second Affiliated Hospital of Kunming Medical UniversityRecruiting5 Years12 YearsBoth15Phase 1/Phase 2China
7NCT02245711
(ClinicalTrials.gov)		December 201012/9/2014Cell Therapy in Limb Girdle Muscular DystrophyIntrathecal Autologous Mononuclear Cell Therapy for Limb Girdle Muscular DystrophyLimb Girdle Muscular DystrophyBiological: Stem CellNeurogen Brain and Spine InstituteNULLWithdrawn15 Years60 YearsAll0Phase 1India
8NCT02241434
(ClinicalTrials.gov)		January 200912/9/2014Stem Cell Therapy in Duchenne Muscular DystrophyThe Role of Autologous Bone Marrow Mononuclear Cell Therapy in Duchenne Muscular DystrophyDuchenne Muscular DystrophyBiological: Stem CellNeurogen Brain and Spine InstituteNULLWithdrawn3 Years25 YearsAll0Phase 1India
9NCT02241928
(ClinicalTrials.gov)		January 200912/9/2014Stem Cell Therapy in Muscular DystrophyRole of Autologous Mononuclear Cell Therapy in Muscular DystrophyMuscular DystrophyBiological: Stem CellNeurogen Brain and Spine InstituteNULLWithdrawn6 Months60 YearsAll0Phase 1India
10NCT02050776
(ClinicalTrials.gov)		December 200829/1/2014Stem Cell Therapy in Limb Girdle Muscular DystrophyThe Role of Cell Therapy in Modifying the Course of Limb Girdle Muscular Dystrophy- A Longitudinal 5-year StudyLimb Girdle Muscular DystrophyBiological: Autologous bone marrow mononuclear cell transplantationNeurogen Brain and Spine InstituteNULLWithdrawn15 Years60 YearsAll0Phase 1India

Back to top